Abstract:Abstract Background WHO reported that HIV infection transmitted through injection drug use has declined; however, some studies have indicated that HIV infection is still high in this population in many countries and these changes are uncertain. We therefore aimed to evaluate the prevalence and trend of HIV infection in opioid and synthetic users in China. Methods We analysed the Drug User Surveillance Database of 3·3 million drug users reported nationwide in China between Jan 1, 2008, and Aug 1, 2016. We included 368 354 individuals who tested for HIV infection for the first time and persistently used opioid or synthetic drugs in our analysis of prevalence and trend of HIV infection. We grouped all participants into three groups according to their HIV status and positions in social networks: individual users (2·6 million users), HIV clustered network (8175 users), and non-HIV network (0·6 million users). The networks were tied by peer relationships, which was defined as both drug users who were reported at the same time, same location, and one of them nominated another user. Relationship of information was extracted from usersu0027 text document record, using breadth first search algorithm and the keywords matching method. The study was approved by Peking University Institutional Review Board. Findings The prevalence of HIV infection was estimated at 3·1% (7236 of 232 415) in opioid users, which was about six times more than in synthetic users (598 [0·4%] of 135 939; adjusted odds ratio [ OR adj ] 5·90, 95% CI 5·37–6·47), but reduced to 2·5 times in injection drug users (2·49, 1·28–4·85). From 2008 to 2015, the prevalence in opioid users presented a U-shaped trend, declining from 3·8% (691 of 18 336) in 2008 to 2·3% (745 of 31 980) in 2010 ( OR adj 0·59, 95% CI 0·53–0·65) and increasing by 4·2% (1074 of 25 622) in 2015 (1·47, 1·33–1·62), while it maintained a stable increase in synthetic users from 0·2% (12 of 5047) in 2009 to 0·6% (234 of 40 336) in 2015 ( OR adj 3·27, 95% CI 1·72–6·21). A total of 226 357 networks were mapped and 1401 networks were identified as HIV clustered networks, which covered 1962 HIV infections. The prevalence of HIV infection in HIV clustered network was 53·4% (1962 of 3675), which was about 25 times ( OR adj 25·69, 95% CI 24·75–26·66) more than 2·1% (7990 of 384 430) in individual users. 75·8% (4324 of 5708) of users in the HIV clustered network were exposed to injection drug use compared with 15·2% (39 158 of 257 126) in the non-HIV cluster network and 26·9% (271 241 of 1 008 561) in individual users. Interpretation HIV infection in opioid users decreased from 2008–10 but subsequently increased from 2010–15, whereas HIV infection keeps increasing stably in synthetic users. Injection drug use in the HIV cluster network is still a high-risk factor and the effect of current strategies on HIV control in drug users, such as the needle and syringe programmes, need to be further estimated. Funding This study was supported by the National Natural Science Foundation of China (grant number 91546203 ) and the Chinese Ministry of Public Security ( 0716-1541GA590508 ).

Further Exploring the Public Health Implications of the Network Scale-Up Method: Cross-Sectional Survey Study

Size estimation of key populations and ‘bridge populations’ based on the network scale-up method in Ukraine

Epidemic of HIV Infection among Persons Who Inject Drugs in Mainland China: a Series, Cross-Sectional Study.

Hiv Knowledge and Risk Behaviour of Female Sex Workers in Yunnan Province, China: Potential As Bridging Groups to the General Population

Identifying the ongoing and local HIV acquisition among newly diagnosed sexually transmitted HIV/AIDS in China: Innovative approach for HIV epidemic surveillance practice (Preprint)

Study on the Dissemination of Human Immunodeficiency Virus Risk Behaviors in a Floating Workers Coming from the Countryside in China

Application of Network Scale Up Method in the Estimation of Population Size for Men Who Have Sex with Men in Shanghai, China

Tracking HIV infection and networks of drugs users in China: a national series, cross-sectional study

Estimating HIV Incidence among Female Sex Workers and Injection Drug Users in Dehong Prefecture, 2009-2017

Estimating the Size of Key Populations in Kampala, Uganda: 3-Source Capture-Recapture Study

A Decline in Hiv and Syphilis Epidemics in Chinese Female Sex Workers (2000-2011): A Systematic Review and Meta-Analysis

Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India

HIV Incidence and Associated Risk Factors among Female Sex Workers in a High HIV-prevalence Area of China.

Reaching and Identifying the STD/HIV Risk of Sex Workers in Beijing

Changes in the Prevalence of HIV-Related Behaviors and Perceptions Among 1832 Injecting Drug Users in Sichuan, China:

Needle and syringe programs in Yunnan, China yield health and financial return

Trends and associated factors in the uptake of HIV testing among female sex workers in Sino-Vietnam border areas in Guangxi, China: a cross-sectional study

Risk behaviours among female sex workers in China: a systematic review and data synthesis.

Association between Drug Co-use Networks and HIV Infection: A Latent Profile Analysis in Chinese Mainland

Comparing Prevalence of Condom Use among 15,379 Female Sex Workers Injecting or Not Injecting Drugs in China.

Drug Use Behaviors and the Risk of HIV Infection Among Drug Users in China Between 2014 and 2021: Cross-Sectional Study